40
Participants
Start Date
May 31, 2014
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
SR-fampridine
"One arm receives SR-fampridine 10 mg BID for 24 weeks followed by four weeks of inactive placebo BID.~The other arm receives placebo BID for 24 weeks followed by four weeks of SR-fampridine 10 mg BID for four weeks."
Placebo
Odense University Hospital, Odense
Sygehus Sønderjylland, Sønderborg
Sydvestjysk Sygehus, Esbjerg
Sygehus Lillebælt, Vejle
Collaborators (1)
Region of Southern Denmark
OTHER
Biogen
INDUSTRY
University of Southern Denmark
OTHER